Researching a potential new way to help people with COPD

Join a clinical study to help us research an investigational medication for COPD

The RPL554-CO-302 Study is looking at a potential new medication (investigational medication) to see how safe it is and whether it works for people with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD).  The study will help us learn whether the investigational medication is able to reduce swelling and widen the airways of the lungs in a single medication.

You may be able to take part if you:

  • are 40-80 years of age

  • Have been diagnosed with COPD

  • Have been, or currently are, a cigarette smoker.

The RPL554-CO-302 Study will last for up to 30 weeks.  All study medication and study-related care will be provided at no cost to you.

IRB approved 14 AUG 2020

Join a Clinical Trial

Research Study:
Ensifentrine over 24 weeks in patients with moderate to severe chronic obstructive pulmonary disease
Please enter your full legal name